Comprehensive update on select immune-mediated gastroenterocolitis syndromes: Implications for diagnosis and management

Radiographics

Volumn 30, Issue 6, 2010, Pages 1465-1487

  Shanbhogue, Alampady Krishna Prasad ^a   Prasad, Srinivasa R ^a   Jagirdar, Jaishree ^a   Takahashi, Naoki ^b   Sandrasegaran, Kumar ^c   Fazzio, Robert T ^b   Fidler, Jeff L ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MAYO CLINIC   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ARTICLE; CELIAC DISEASE; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; EOSINOPHILIC ESOPHAGITIS; GASTROENTERITIS; GENETICS; HUMAN; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

CELIAC DISEASE; COLITIS; CONTRAST MEDIA; CROHN DISEASE; EOSINOPHILIC ESOPHAGITIS; GASTROENTERITIS; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78149385342     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.306105520     Document Type: Article

References (62)

1. Pickard KM, Bremner AR, Gordon JN, MacDonald TT. Microbial-gut interactions in health and disease: immune responses. Best Pract Res Clin Gastroenterol 2004;18(2):271-285.
2. Honda K, Takeda K. Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol 2009;2(3):187-196.
3. Blumberg RS, Li L, Nusrat A, Parkos CA, Rubin DC, Carrington JL. Recent insights into the integration of the intestinal epithelium within the mucosal environment in health and disease. Mucosal Immunol 2008;1(5):330-334.
4. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005;307 (5717):1920-1925.
5. Westerberg DP, Gill JM, Dave B, DiPrinzio MJ, Quisel A, Foy A. New strategies for diagnosis and management of celiac disease. J Am Osteopath Assoc 2006;106(3):145-151.
6. Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, Melton LJ 3rd. Trends in the identification and clinical features of celiac disease in a North American community: 1950-2001. Clin Gastroenterol Hepatol 2003;1(1):19-27.
7. Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 2005;128(4 suppl 1): S47-S51.
8. Ciclitira PJ, Moodie SJ. Transition of care between paediatric and adult gastroenterology: coeliac disease. Best Pract Res Clin Gastroenterol 2003;17(2): 181-195.
9. Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50(5):624-628.
10. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346(3):180-188.
11. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102 (1):330-354.
12. Soyer P, Boudiaf M, Dray X, et al. CT enteroclysis features of uncomplicated celiac disease: retrospective analysis of 44 patients. Radiology 2009;253(2): 416-424.
13. Herlinger H, Maglinte DD. Jejunal fold separation in adult celiac disease: relevance of enteroclysis. Radiology 1986;158(3):605-611.
14. Buckley O, Brien JO, Ward E, Doody O, Govender P, Torreggiani WC. The imaging of coeliac disease and its complications. Eur J Radiol 2008;65(3): 483-490.
15. Trier JS. Celiac sprue. N Engl J Med 1991;325 (24):1709-1719.
16. Swinson CM, Slavin G, Coles EC, Booth CC. Coeliac disease and malignancy. Lancet 1983;1(8316): 111-115.
17. Howat AJ, McPhie JL, Smith DA, et al. Cavitation of mesenteric lymph nodes: a rare complication of coeliac disease, associated with a poor outcome. Histopathology 1995;27(4):349-354.
18. Rubesin SE, Herlinger H, Saul SH, Grumbach K, Laufer I, Levine MS. Adult celiac disease and its complications. RadioGraphics 1989;9(6):1045-1066.
19. Wright DH. The major complications of celiac disease. Baillieres Clin Gastroenterol 1995;9(2): 351-369.
20. Pink IJ, Creamer B. Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1967; 1(7485):300-304.
21. Cummins AG, Thompson FM, Butler RN, et al. Improvement in intestinal permeability precedes morphometric recovery of the small intestine in celiac disease. Clin Sci (Lond) 2001;100(4):379-386.
22. Blanchard C, Wang N, Rothenberg ME. Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol 2006;118(5): 1054-1059.
23. Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005;115(2):418-419.
24. Yan BM, Shaffer EA. Primary eosinophilic disorders of the gastrointestinal tract. Gut 2009;58(5): 721-732.
25. Quaglietta L, Coccorullo P, Miele E, Pascarella F, Troncone R, Staiano A. Eosinophilic oesophagitis and coeliac disease: is there an association? Aliment Pharmacol Ther 2007;26(3):487-493.
26. Furuta GT. Emerging questions regarding eosinophil's role in the esophago-gastrointestinal tract. Curr Opin Gastroenterol 2006;22(6):658-663.
27. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133(4):1342-1363.
28. Binkovitz LA, Lorenz EA, Di Lorenzo C, Kahwash S. Pediatric eosinophilic esophagitis: radiologic findings with pathologic correlation. Pediatr Radiol 2010;40(5):714-719.
29. Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006;4(9):1097-1102.
30. Khan S. Eosinophilic gastroenteritis. Best Pract Res Clin Gastroenterol 2005;19(2):177-198.
31. Daneshjoo R, J Talley N. Eosinophilic gastroenteritis. Curr Gastroenterol Rep 2002;4(5):366-372.
32. McNabb PC, Fleming CR, Higgins JA, Davis GL. Transmural eosinophilic gastroenteritis with ascites. Mayo Clin Proc 1979;54(2):119-122.
33. Pratt CA, Demain JG, Rathkopf MM. Food allergy and eosinophilic gastrointestinal disorders: guiding our diagnosis and treatment. Curr Probl Pediatr Adolesc Health Care 2008;38(6):170-188.
34. Ertuǧrul I, Ulker A, Turhan N, Daǧli U, Saşmaz N. Eosinophilic colitis as an unusual cause of severe bloody diarrhea. Turk J Gastroenterol 2008;19(1): 54-56.
35. Read NW, Krejs GJ, Read MG, Santa Ana CA, Morawski SG, Fordtran JS. Chronic diarrhea of unknown origin. Gastroenterology 1980;78(2): 264-271.
36. Bohr J, Olesen M, Tysk C, Järnerot G. Collagenous and lymphocytic colitis: a clinical and histopathological review. Can J Gastroenterol 2000;14(11): 943-947.
37. Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol 2002;97(4):794-802.
38. Zins BJ, Sandborn WJ, Tremaine WJ. Collagenous and lymphocytic colitis: subject review and therapeutic alternatives. Am J Gastroenterol 1995;90(9): 1394-1400.
39. Fernández-Bañares F, Salas A, Forné M, Esteve M, Espinós J, Viver JM. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999;94(2):418-423.
40. Fine KD, Do K, Schulte K, et al. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol 2000;95(8):1974-1982.
41. Tanaka M, Mazzoleni G, Riddell RH. Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut 1992;33(1):65-70.
42. Fernández-Bañares F, Salas A, Esteve M, Espinós J, Forné M, Viver JM. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003;98(2):340-347.
43. Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325(13):928-937.
44. Loftus EV Jr. Clinical epidemiology of inflamatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126(6): 1504-1517.
45. Karlinger K, Györke T, Makö E, Mester A, Tarján Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000;35(3): 154-167.
46. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79(2):200-206.
47. Ghosh S, Shand A, Ferguson A. Ulcerative colitis. BMJ 2000;320(7242):1119-1123.
48. Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 2009;251(3): 751-761.
49. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009;193(1):113-121.
50. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol 2001;177(6):1325-1332.
51. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000;25(3):219-228.
52. Canani RB, de Horatio LT, Terrin G, et al. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2006;42(1):9-15.
53. Bennink RJ, Peeters M, Rutgeerts P, Mortelmans L. Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy. J Nucl Med 2004;45(10):1698-1704.
54. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002;16(1):51-60.
55. Bateman AC, Deheragoda MG. IgG4-related systemic sclerosing disease: an emerging and underdiagnosed condition. Histopathology 2009;55(4): 373-383.
56. Shanbhogue AK, Fasih N, Surabhi VR, Doherty GP, Shanbhogue DK, Sethi SK. A clinical and radiologic review of uncommon types and causes of pancreatitis. RadioGraphics 2009;29(4):1003-1026.
57. Kaji R, Okabe Y, Ishida Y, et al. Autoimmune pancreatitis presenting with IgG4-positive multiple gastric polyps. Gastrointest Endosc 2010;71(2): 420-422.
58. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010 Mar 27. [Epub ahead of print]
59. Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: a systematic literature review and metaanalysis. J Gastroenterol Hepatol 2009;24(1):15-36.
60. Russo PA, Brochu P, Seidman EG, Roy CC. Autoimmune enteropathy. Pediatr Dev Pathol 1999;2(1): 65-71.
61. Ruemmele FM, Moes N, de Serre NP, Rieux-Laucat F, Goulet O. Clinical and molecular aspects of autoimmune enteropathy and immune dysregulation, polyendocrinopathy autoimmune enteropathy X-linked syndrome. Curr Opin Gastroenterol 2008;24(6):742-748.
62. Kobayashi I, Nakanishi M, Okano M, Sakiyama Y, Matsumoto S. Combination therapy with tacrolimus and betamethasone for a patient with X-linked autoimmune enteropathy. Eur J Pediatr 1995;154(7): 594-595.